CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway

Biochemical and Biophysical Research Communications

Volumn 456, Issue 1, 2015, Pages 373-379

  Wang, Yiting ^a   Tu, Qunfei ^a   Yan, Wei ^a   Xiao, Dan ^a   Zeng, Zhimin ^a   Ouyang, Yuming ^a   Huang, Long ^a   Cai, Jing ^a   Zeng, Xiaoli ^a   Chen, Ya Jie ^a   Liu, Anwen ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

CXC195; Hepatocellular carcinoma; Inflammation; NF B; Proliferation; TLR4

Indexed keywords

ANTINEOPLASTIC AGENT; CXC 195; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOID DIFFERENTIATION FACTOR 88; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MYD88 PROTEIN, HUMAN; PIPERAZINE DERIVATIVE; PYRAZINE DERIVATIVE; TLR4 PROTEIN, HUMAN;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN PHOSPHORYLATION; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; INFLAMMATION; LIVER TUMOR; METABOLISM; SIGNAL TRANSDUCTION;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER NEOPLASMS; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PIPERAZINES; PYRAZINES; TOLL-LIKE RECEPTOR 4;

EID: 84919691366     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.11.090     Document Type: Article

References (26)

1. D.M. Parkin, F.I. Bray, and S.S. Devesa Cancer burden in the year 2000. The global picture Eur. J. Cancer 37 Suppl. 8 2001 S4 S66
2. P.A. Farazi, and R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nat. Rev. Cancer 6 2006 674 687
3. A. Forner, J.M. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
4. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
5. D.H. Dapito, A. Mencin, G.Y. Gwak, J.P. Pradere, M.K. Jang, I. Mederacke, J.M. Caviglia, H. Khiabanian, A. Adeyemi, R. Bataller, J.H. Lefkowitch, M. Bower, R. Friedman, R.B. Sartor, R. Rabadan, and R.F. Schwabe Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4 Cancer Cell 21 2012 504 516
6. L.X. Yu, H.X. Yan, Q. Liu, W. Yang, H.P. Wu, W. Dong, L. Tang, Y. Lin, Y.Q. He, S.S. Zou, C. Wang, H.L. Zhang, G.W. Cao, M.C. Wu, and H.Y. Wang Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents Hepatology 52 2010 1322 1333
7. L. Wang, R. Zhu, Z. Huang, H. Li, and H. Zhu Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma Dig. Dis. Sci. 58 2013 2223 2236
8. C.Y. Zheng, W. Xiao, M.X. Zhu, X.J. Pan, Z.H. Yang, and S.Y. Zhou Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasis Int. J. Oncol. 40 2012 2029 2037
9. Y. Wang, Q. Fu, and W. Zhao Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo Mol. Med. Rep. 8 2013 984 988
10. K. Yu, Z. Chen, X. Pan, Y. Yang, S. Tian, J. Zhang, J. Ge, B. Ambati, and J. Zhuang Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression Oncol. Rep. 28 2012 955 960
11. Y.S. Fu, Y.Y. Lin, S.C. Chou, T.H. Tsai, L.S. Kao, S.Y. Hsu, F.C. Cheng, Y.H. Shih, H. Cheng, Y.Y. Fu, and J.Y. Wang Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: potential therapeutic application for treatment of gliomas Neuro Oncol. 10 2008 139 152
12. J. Yin, C. Yu, Z. Yang, J.L. He, W.J. Chen, H.Z. Liu, W.M. Li, H.T. Liu, and Y.X. Wang Tetramethylpyrazine inhibits migration of SKOV3 human ovarian carcinoma cells and decreases the expression of interleukin-8 via the ERK1/2, p38 and AP-1 signaling pathways Oncol. Rep. 26 2011 671 679
13. Y. Zhang, X. Liu, T. Zuo, Y. Liu, and J.H. Zhang Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein Med. Oncol. 29 2012 534 538
14. B. Yi, D. Liu, M. He, Q. Li, T. Liu, and J. Shao Role of the ROS/AMPK signaling pathway in tetramethylpyrazine-induced apoptosis in gastric cancer cells Oncol. Lett. 6 2013 583 589
15. X.B. Wang, S.S. Wang, Q.F. Zhang, M. Liu, H.L. Li, Y. Liu, J.N. Wang, F. Zheng, L.Y. Guo, and J.Z. Xiang Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells Oncol. Rep. 23 2010 211 215
16. X.C. Cheng, X.Y. Liu, W.F. Xu, X.L. Guo, and Y. Ou Design, synthesis, and biological activities of novel Ligustrazine derivatives Bioorg. Med. Chem. 15 2007 3315 3320
17. Y. Ou, X. Dong, X.Y. Liu, X.C. Cheng, Y.N. Cheng, L.G. Yu, and X.L. Guo Mechanism of tetramethylpyrazine analogue CXC195 inhibition of hydrogen peroxide-induced apoptosis in human endothelial cells Biol. Pharm. Bull. 33 2010 432 438
18. H. Liu, X. Wei, L. Chen, X. Liu, S. Li, X. Liu, and X. Zhang Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion injury in the rat by an antioxidant action via inhibition of NADPH oxidase and iNOS expression Pharmacology 92 2013 198 206
19. L. Chen, X. Wei, Y. Hou, X. Liu, S. Li, B. Sun, X. Liu, and H. Liu Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats Neurochem. Int. 66 2014 27 32
20. H.J. Hartwell, K.Y. Petrosky, J.G. Fox, N.D. Horseman, and A.B. Rogers Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice Proc. Natl. Acad. Sci. U.S.A. 111 2014 11455 11460
21. F. Iannelli, A. Collino, S. Sinha, E. Radaelli, P. Nicoli, L. D'Antiga, A. Sonzogni, J. Faivre, M.A. Buendia, E. Sturm, R.J. Thompson, A.S. Knisely, G. Natoli, S. Ghisletti, and F.D. Ciccarelli Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency Nat. Commun. 5 2014 3850
22. B.F. Ning, J. Ding, J. Liu, C. Yin, W.P. Xu, W.M. Cong, Q. Zhang, F. Chen, T. Han, X. Deng, P.Q. Wang, C.F. Jiang, J.P. Zhang, X. Zhang, H.Y. Wang, and W.F. Xie Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression Hepatology 60 2014 1607 1619
23. J.J. Huang, H.X. Chu, Z.Y. Jiang, X.J. Zhang, H.P. Sun, and Q.D. You Recent advances in the structure-based and ligand-based design of IKKβ inhibitors as anti-inflammation and anti-cancer agents Curr. Med. Chem. 2014
24. Y. Li, X. Shi, J. Zhang, X. Zhang, and R.C. Martin Hepatic protection and anticancer activity of curcuma: a potential chemopreventive strategy against hepatocellular carcinoma Int. J. Oncol. 44 2014 505 513
25. M. Yamamoto, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway Science 301 2003 640 643
26. J.C. Kagan, and R. Medzhitov Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling Cell 125 2006 943 955